Quote:
Originally Posted by GoodLife
There have been many medical studies done testing HCQ effectiveness. There are more positive studies than there are negative ones. In general (not all) the negative studies used the drug on severely sick patients while the more positive ones used the drug earlier, before the disease had progressed to ICU/ventilator stage.
Here is a link to 65 studies, 39 or which were peer reviewed. Peer review does not always guarantee authenticity of results, the infamous Surgisphere study published in Lancet was peer reviewed and then retracted because of fraudulent data.
COVID-19 Treatment - Analysis of 65 global studies showing high effectiveness for early treatment
The most recent positive study was recently released by Henry Ford Health in Michigan and treatment with HCQ cut the death rate significantly in sick hospitalized patients, no heart-related side-effects. HCQ decreases mortality from 26.4% to 13.5% in 2451 patients.
https://www.ijidonline.com/article/S...534-8/fulltext |
Very interesting, clear there is much to learn managing this disease, thanks for posting.